France requests revision of controversial virus drug

bottle of hydroxychloroquine tablets on shelf
The French health minister has requested a "revision" to the rules in France after a study in The Lancet said: "We were unable to confirm a benefit of hydroxychloroquine or chloroquine" and even suggested it could heighten risk

France has demanded a revision of the rules for prescribing controversial Covid-19 treatment hydroxychloroquine (HCQ), after a study was published suggesting that the drug is ineffective.

French minister for health Olivier Véran this weekend (Saturday May 23) has requested that medical authority Haut Conseil de la Santé Publique (HCSP) present “within 48 hours, a revision of the rules that allow exceptional prescription”.

The request comes after a new study, published on Friday May 22 in medical journal The Lancet, suggested that HCQ was ineffective against Covid-19, and could even present additional risks to patients.

The study, on 96,000 patients, concluded that neither chloroquine nor HCQ were effective against Covid-19 in hospitalised patients, and that the drugs ...

To read the remaining 85% of this article, you need to either

Subscribe now to The Connexion and benefit from access to our archived articles since 2006

Print + Digital 3 month subscription

Pay every three months. Our most flexible subscription.

Automatic renewal, cancel anytime

Print + Digital 1 year subscription

1 year of great reading in print and online

Automatic renewal, cancel anytime

Digital 1 year subscription (Our best value offer)

1 year of great reading online *no paper*

Automatic renewal, cancel anytime

Digital 3 month subscription

3 months of great reading online *no paper*

Automatic renewal, cancel anytime

More articles from French news
More articles from Connexion France
Other articles that may interest you